Last reviewed · How we verify
NCT03449277
Oral Nifedipine Versus Labetalol in Treatment of Postpartum Hypertension
Phase 4 trial testing Oral Tablet in Postpartum Preeclampsia in 100 participants. Status unknown.
1 February 2019
Quick facts
| Lead sponsor | Hossam Ahmed Abd Ellah |
|---|---|
| Phase | Phase 4 |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 100 |
| Start date | 19 January 2018 |
| Primary completion | 1 February 2019 |
| Estimated completion | 1 March 2019 |
| Sites | 1 location across Egypt |
Drugs / interventions tested
- Oral Tablet
Conditions studied
- Postpartum Preeclampsia — all drugs for Postpartum Preeclampsia →
Sponsor
Hossam Ahmed Abd Ellah
Who can join
Adults 20 to 40, female only, with Postpartum Preeclampsia. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Hypertensive disorders of pregnancy are important cause of severe morbidity, long-term disability and death among both mothers and their babies. In Africa and Asia, nearly one tenth of all maternal deaths are associated with hypertensive disorders of pregnancy research has focused on the antenatal complications' for both mother and baby and the risks and benefits of administering antihypertensive therapy prior to delivery hypertension disorders of pregnancy often persist following delivery and sometimes arise de novo postpartum one of the maternal complications of pre eclampsia is residual chronic hypertension in about 1/3 of cases elevated blood pressure is seen in 6%to 8% of all pregnancies hypertension (arterial pressure \>140/90 mmhg) in pregnancy is classified into one of four conditions 1. chronic hypertension that precedes pregnancy 2. pre eclampsia and eclampsia: a systematic syndrome of elevated arterial pressure,proteinuria and other findings 3. pre eclampsia superimposed upon chronic hypertension 4. gestational hypertension or nonproteinuric hypertension of pregnancy
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT03449277
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Oral Tablet
Trials testing the same drug.
- NCT03908567 — AM-125 in the Treatment of Acute Peripheral Vertigo Following Neurosurgery · Phase 2 · completed
- NCT03220074 — Linezolid for Treatment of Nontuberculous Mycobacterial Diseases · Phase 4 · completed
Other recruiting trials for Postpartum Preeclampsia
Currently open trials in the same condition.
- NCT06842875 — Rhode Island - Statewide Postpartum Hypertension Remote Surveillance · NA · recruiting
- NCT05309460 — Labetalol or Nifedipine for Control of Postpartum Hypertension: A Randomized Controlled Trial · Phase 4 · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03449277 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Hossam Ahmed Abd Ellah
- Last refreshed: 4 April 2018
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03449277.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing